Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · HIV/AIDS

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Bae: AZT/3TC/NVP vs Other Short Course PMTCT Regimen

Stillbirth · ART‐Eligible HIV‐infected Pregnant Women

It is very uncertain whether ekouevi: AZT/3TC/NVP changes stillbirths compared with other Short Course PMTCT Regimen (very low certainty).

1 finding from 1 review

Antiretroviral therapy (ART) for treating HIV infection in ART‐eligible pregnant women 2010 · Cochrane Headline outcomes only
RR 1.16 [0.34, 3.93]
1 study · 326 participants
Very low

Bae: AZT/3TC/NVP vs Other Short Course PMTCT Regimen

Low birthweight · ART‐Eligible HIV‐infected Pregnant Women

It is very uncertain whether ekouevi: AZT/3TC/NVP changes infant Low Birth Weight compared with other Short Course PMTCT Regimen (very low certainty).

1 finding from 1 review

Antiretroviral therapy (ART) for treating HIV infection in ART‐eligible pregnant women 2010 · Cochrane Headline outcomes only
RR 1.81 [1.09, 3]
1 study · 309 participants
Very low

Bae: AZT/3TC/NVP vs Other Short Course PMTCT Regimen

Mother to Child Transmission at 12 Months · ART‐Eligible HIV‐infected Pregnant Women

It is very uncertain whether ekouevi: AZT/3TC/NVP changes mother to Child Transmission at 12 Months compared with other Short Course PMTCT Regimen (very low certainty).

1 finding from 1 review

Antiretroviral therapy (ART) for treating HIV infection in ART‐eligible pregnant women 2010 · Cochrane Headline outcomes only
RR 0.14 [0.04, 0.47]
1 study · 311 participants
Very low